Business · 09/03/2001Updated: 10/17/2026 · 1 min read
FDA Releases Guidance on Expedited Review Process for New Animal Drugs Reducing Human Pathogens
Summary
The Food and Drug Administration (FDA) has made available a guidance document (#121) outlining the process for granting expedited review status for new animal drug applications aimed at reducing human pathogens in food-producing animals
Original source language: Federal Register — Food and Drug AdministrationOpen original release →